The Indian Pharmaceutical Market (IPM) maintained moderate growth in April 2025, expanding 7.8% year-on-year in value. Monthly sales reached roughly ₹19,700 crore, reflecting a continuation of the mid-single-digit growth trend seen in the first quarter of 2025.
However, volume growth remained muted at only ~1.3%, indicating that higher prices and new product sales rather than sheer increase in demand drove most of the value gain. This comes on the heels of a 7.5% growth in March and suggests a stable but price-driven market expansion going into the new fiscal year .
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
